Skip to content
Baret News – Lifestyle
Author:
IN8bio, Inc
IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
June 1, 2026
IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 21, 2026
←
Previous Page
1
2